Literature DB >> 7730144

Isolation and properties of tumor-derived endothelial cells from rat KMT-17 fibrosarcoma.

N Utoguchi1, A Dantakean, H Makimoto, Y Wakai, Y Tsutsumi, S Nakagawa, T Mayumi.   

Abstract

Rat KMT-17 fibrosarcoma-derived endothelial cells were isolated by Percoll gradient centrifugation with an attaching-speed separation technique, and their properties in culture were examined. The primary cultured tumor-derived endothelial cells (TEC) showed angiotensin-converting enzyme activity, positivity for Factor VIII-related antigen staining, and typical capillary-like formation on Matrigel. The primary cultured TEC monolayer showed greater permeability than normal tissue-derived endothelial cell (aorta, vena cava and epididymal fat capillary) monolayers on FITC-dextran diffusion (molecular weight 70,000). Leukocyte adhesion to TEC was reduced compared to that to fat-derived capillary endothelial cells. These characteristics resembled those of tumor vascular endothelium, and were observed both in the primary and first-passage cell cultures, but not in the fourth-passage cell cultures. Our findings indicate that primary or subcultured TEC are applicable for studies of the physiological characteristics of tumor endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730144      PMCID: PMC5920755          DOI: 10.1111/j.1349-7006.1995.tb03039.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  55 in total

1.  Transcellular transport of fluorescein dextran through an arterial endothelial cell monolayer.

Authors:  R Hashida; C Anamizu; Y Yagyu-Mizuno; S Ohkuma; T Takano
Journal:  Cell Struct Funct       Date:  1986-12       Impact factor: 2.212

2.  Basic fibroblast growth factor induces angiogenesis in vitro.

Authors:  R Montesano; J D Vassalli; A Baird; R Guillemin; L Orci
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

Authors:  M Fràter-Schröder; W Risau; R Hallmann; P Gautschi; P Böhlen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  The ultrastructure and permeability characteristics of the blood vessels of a transplantable rat sarcoma.

Authors:  J C Underwood; I Carr
Journal:  J Pathol       Date:  1972-07       Impact factor: 7.996

5.  Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.

Authors:  S Kondo; M Asano; H Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1993-08-16       Impact factor: 3.575

Review 6.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

7.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors:  D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

8.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

Review 9.  Isolation and culture of pulmonary endothelial cells.

Authors:  U S Ryan
Journal:  Environ Health Perspect       Date:  1984-06       Impact factor: 9.031

10.  An electron microscopic correlation of structure with function in the isolated perfused cow adrenal, preliminary observations.

Authors:  J LUFT; O HECHTER
Journal:  J Biophys Biochem Cytol       Date:  1957-07-25
View more
  3 in total

1.  Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy.

Authors:  S Tsunoda; I Ohizumi; J Matsui; K Koizumi; Y Wakai; H Makimoto; Y Tsutsumi; N Utoguchi; K Taniguchi; H Saito; N Harada; Y Ohsugi; T Mayumi
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

2.  Preferential activity of wild-type and mutant tumor necrosis factor-alpha against tumor-derived endothelial-like cells.

Authors:  K Kuroda; K Miyata; Y Tsutsumi; S Tsunoda; K Nishimura; Y Mitsuishi; S Nakagawa; T Mayumi
Journal:  Jpn J Cancer Res       Date:  2000-01

3.  Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23).

Authors:  Y Wakai; J Matsui; K Koizumi; S Tsunoda; H Makimoto; I Ohizumi; K Taniguchi; S Kaiho; H Saito; N Utoguchi; Y Tsutsumi; S Nakagawa; Y Ohsugi; T Mayumi
Journal:  Jpn J Cancer Res       Date:  2000-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.